Gazi University Medicine Faculty Hospital

Ankara 06590

1 studies enrolling now · 2 studies all time

What they study most

Mucopolysaccharidosis II, Non-Small Cell Lung Cancer

Studies at this site

• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT) — Running, not enrolling